Imidazopiperidine amides as dipeptidyl peptidase IV inhibitors for the treatment of diabetes was written by Chen, Ping;Caldwell, Charles G.;Mathvink, Robert J.;Leiting, Barbara;Marsilio, Frank;Patel, Reshma A.;Wu, Joseph K.;He, Huaibing;Lyons, Kathryn A.;Thornberry, Nancy A.;Weber, Ann E.. And the article was included in Bioorganic & Medicinal Chemistry Letters in 2007.Name: tert-Butyl 5,6-dihydropyridine-1(2H)-carboxylate This article mentions the following:
A series of substituted imidazopiperidine amides has been prepared and evaluated for inhibition of dipeptidyl peptidase IV (DPP-4). Substitution at the 1- and 3-positions produced increased selectivity for DPP-4 relative to DPP-8 and DPP-9. Compounds in this series had IC50 values as low as 5.8 nM for inhibition of DPP-4. In the experiment, the researchers used many compounds, for example, tert-Butyl 5,6-dihydropyridine-1(2H)-carboxylate (cas: 85838-94-4Name: tert-Butyl 5,6-dihydropyridine-1(2H)-carboxylate).
tert-Butyl 5,6-dihydropyridine-1(2H)-carboxylate (cas: 85838-94-4) belongs to pyridine derivatives. Pyridines are an important class of heterocycles and occur in polysubstituted forms in many naturally occurring biologically active compounds, drug molecules and chiral ligands. Pyridine groups exist in countless molecules, and their applications include catalysis, drug design, molecular recognition, and natural product synthesis.Name: tert-Butyl 5,6-dihydropyridine-1(2H)-carboxylate